SkarLite Sheet by Skya Health, LLC. SkarLite Sheet

SkarLite Sheet by

Drug Labeling and Warnings

SkarLite Sheet by is a Other medication manufactured, distributed, or labeled by Skya Health, LLC.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

SKARLITE SHEET- elastomer, silicone, for scar management patch 
Skya Health, LLC.

----------

SkarLite Sheet

SKARLITE SHEET- elastomer, silicone, for scar management patch 

Skya Health, LLC

----------

SKARLITE SHEET 

Skya Health, LLC

SKARLITE SHEET (Silicone Gel Matrix) Rx only

For external use only Not for ophthalmic use

SKARLITE SHEET Description

SKARLITE SHEET is intended for use in the management of closed hyperproliferative scars, both old and new hypertrophic or keloid scars resulting from burns, surgical procedures, or trauma wounds.

Each SKARLITE SHEET contains: Silicone, Polydimethylsiloxane, Vinyltriethoxysilane, Organotin catalyst, and pure water.

CLINICAL PHARMACOLOGY

The exact mechanism of action in improving the appearance of scar tissue from using silicone remains unknown. However, various suggestions have been made to explain the efficacy of silicone sheets, including hydration, pressure, temperature, oxygen transmission and silicone absorption. There is some evidence that the treatment affects the stratum corneum and, by reducing evaporation, restores better homeostasis in the tissue. In keloid and hypertrophic scarring, the stratum corneum allows more evaporation of water from the underlying tissue than occurs in normal skin. Silicone pads may prevent this, keeping the stratum corneum in optimal hydration and protecting the skin from environmental hazards, both of which can reduce abnormal scarring. The gel may also affect the stratum corneum by inhibiting mast cell activity, diminishing edema, vasodilatation, and excessive extracellular matrix formation but the simple changes in temperature, pressure, oxygen tension and hydration produced by wound coverage probably constitute the main mechanism of action. Another hypothesis is that the effect of static electricity on silicone may influence the alignment of collagen deposition.

INDICATIONS AND USES

For use in the management of closed hyperproliferative (hypertrophic or keloid) scars.

CONTRAINDICATIONS

SKARLITE SHEET is contraindicated in patients with known hypersensitivity to silicone or any of the listed ingredients.

WARNINGS

For external use only. Avoid contact with eyes, lips or mucous membranes. Do not apply on areas of broken skin. Do not apply on third degree burns and open wounds. Never use on sutured wound until sutures have been removed.

PRECAUTIONS

Stop use and ask a doctor if irritation develops. In rare instances, silicone sheets may cause a rash on the skin. This condition may result from improper cleansing of the scar area where the silicone pad has been applied. If this product is applied properly and skin irritation still occurs, discontinue use and consult your physician. If ingested, get medical help or contact Poison Control Center right away.

KEEP THIS AND ALL MEDICATION OUT OF THE REACH OF CHILDREN.

This medication should be used as directed by your physician during pregnancy or while breastfeeding. Consult your doctor about the risks and benefits.

CAUTION: Federal law restricts this device to sale by or on the order of a physician.

ADVERSE REACTIONS

On rare occasions, the Pads may cause temporary redness, stinging, burning or irritation and normally disappear when the medication is discontinued.

DOSAGE AND ADMINISTRATION

  1. Wash hands and scar area thoroughly with soap and water. Completely dry the area after.
  2. If needed, cut the SKARLITE SHEET to size making sure to leave at least 1/4” beyond the area of the scar.
  3. Peel off the backing of the sheet and place it sticky side down on the affected area.
  4. For best results, leave on for 8-12 hours. When finished, dispose of sheet.
  5. Change gel pad once a day until no longer needed.

How is SKARLITE SHEET Supplied

SKARLITE SHEET (Silicone Gel Matrix) is supplied in:

Seven (7) Large Non-Sterile Silicone Gel Pads – 1.57" × 5.12" in 1 Carton NDC: 73086-805-97

Fourteen (14) Large Non-Sterile Silicone Gel Pads – 1.57" × 5.12" in 1 Carton NDC: 73086-805-98

Twenty eight (28) Large Non-Sterile Silicone Gel Pads – 1.57" × 5.12" in 1 Carton NDC: 73086-805-99

Store at 20°-25°C (68° to 77°F); Keep away from heat and protect from freezing. [See USP Controlled Room Temperature.]

Packaged for:
Skya Health, LLC
West Covina, CA 91790

PRINCIPAL DISPLAY PANEL

NDC: 73086-805-97 Rx ONLY

SkarLite Sheet

7-Day Supply

PRINCIPAL DISPLAY PANEL
NDC: <a href=/NDC/73086-805-97>73086-805-97</a> Rx ONLY
SkarLite Sheet

7-Day Supply

PRINCIPAL DISPLAY PANEL

NDC: 73086-805-98 Rx ONLY

SkarLite Sheet

14-Day Supply

73086-805-98 SkarLite Sheet 14 pack 4.5 x 6-01.jpg

PRINCIPAL DISPLAY PANEL

NDC: 73086-805-99 Rx ONLY

SkarLite Sheet

28-Day Supply

NDC: <a href=/NDC/73086-805-99>73086-805-99</a> Rx ONLY
SkarLite Sheet

28-Day Supply

SKARLITE SHEET 
elastomer, silicone, for scar management patch
Product Information
Product TypeMEDICAL DEVICEItem Code (Source)NHRIC:73086-805
Route of AdministrationTOPICAL
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NHRIC:73086-805-977 in 1 CARTON; Type 0: Not a Combination Product
2NHRIC:73086-805-9814 in 1 CARTON; Type 0: Not a Combination Product
3NHRIC:73086-805-9928 in 1 CARTON; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
EXEMPT DEVICEMDA01/19/202108/14/2023
Labeler - Skya Health, LLC. (117039304)

Revised: 8/2023
 

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.